Cargando…
Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with inherited forms of Parkinson’s disease (PD), causing disease by a gain of kinase function. Here, we describe a series of isogenic iPSC lines with any of five pathogenic mutations (N1437H, R1441C, Y1699C, G2019S and I2020T); two hy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314873/ https://www.ncbi.nlm.nih.gov/pubmed/34087985 http://dx.doi.org/10.1016/j.scr.2021.102354 |
_version_ | 1783729626885914624 |
---|---|
author | Beylina, Aleksandra Langston, Rebekah G. Rosen, Dorien Reed, Xylena Cookson, Mark R. |
author_facet | Beylina, Aleksandra Langston, Rebekah G. Rosen, Dorien Reed, Xylena Cookson, Mark R. |
author_sort | Beylina, Aleksandra |
collection | PubMed |
description | Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with inherited forms of Parkinson’s disease (PD), causing disease by a gain of kinase function. Here, we describe a series of isogenic iPSC lines with any of five pathogenic mutations (N1437H, R1441C, Y1699C, G2019S and I2020T); two hypothesis testing mutations (GTP binding null, T1348N, and kinase dead, K1906M) and two LRRK2 knockouts. This resource could be used to assess effects of mutations on the function of endogenous LRRK2 and/or to study LRRK2 interactors and substrates in iPSC-derived cellular models. |
format | Online Article Text |
id | pubmed-8314873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-83148732021-07-27 Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) Beylina, Aleksandra Langston, Rebekah G. Rosen, Dorien Reed, Xylena Cookson, Mark R. Stem Cell Res Article Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with inherited forms of Parkinson’s disease (PD), causing disease by a gain of kinase function. Here, we describe a series of isogenic iPSC lines with any of five pathogenic mutations (N1437H, R1441C, Y1699C, G2019S and I2020T); two hypothesis testing mutations (GTP binding null, T1348N, and kinase dead, K1906M) and two LRRK2 knockouts. This resource could be used to assess effects of mutations on the function of endogenous LRRK2 and/or to study LRRK2 interactors and substrates in iPSC-derived cellular models. 2021-04-15 2021-05 /pmc/articles/PMC8314873/ /pubmed/34087985 http://dx.doi.org/10.1016/j.scr.2021.102354 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license. |
spellingShingle | Article Beylina, Aleksandra Langston, Rebekah G. Rosen, Dorien Reed, Xylena Cookson, Mark R. Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title | Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title_full | Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title_fullStr | Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title_full_unstemmed | Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title_short | Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2) |
title_sort | generation of fourteen isogenic cell lines for parkinson’s disease-associated leucine-rich repeat kinase (lrrk2) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314873/ https://www.ncbi.nlm.nih.gov/pubmed/34087985 http://dx.doi.org/10.1016/j.scr.2021.102354 |
work_keys_str_mv | AT beylinaaleksandra generationoffourteenisogeniccelllinesforparkinsonsdiseaseassociatedleucinerichrepeatkinaselrrk2 AT langstonrebekahg generationoffourteenisogeniccelllinesforparkinsonsdiseaseassociatedleucinerichrepeatkinaselrrk2 AT rosendorien generationoffourteenisogeniccelllinesforparkinsonsdiseaseassociatedleucinerichrepeatkinaselrrk2 AT reedxylena generationoffourteenisogeniccelllinesforparkinsonsdiseaseassociatedleucinerichrepeatkinaselrrk2 AT cooksonmarkr generationoffourteenisogeniccelllinesforparkinsonsdiseaseassociatedleucinerichrepeatkinaselrrk2 |